FR2235949B1 - - Google Patents

Info

Publication number
FR2235949B1
FR2235949B1 FR7322114A FR7322114A FR2235949B1 FR 2235949 B1 FR2235949 B1 FR 2235949B1 FR 7322114 A FR7322114 A FR 7322114A FR 7322114 A FR7322114 A FR 7322114A FR 2235949 B1 FR2235949 B1 FR 2235949B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7322114A
Other languages
French (fr)
Other versions
FR2235949A1 (US06330241-20011211-M00004.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7322114A priority Critical patent/FR2235949B1/fr
Priority to SE7407108A priority patent/SE402461B/xx
Priority to ES427318A priority patent/ES427318A1/es
Priority to DK322274A priority patent/DK322274A/da
Priority to US479889A priority patent/US3922292A/en
Priority to CA202,616A priority patent/CA1032927A/en
Priority to ZA00743841A priority patent/ZA743841B/xx
Priority to NL7408041A priority patent/NL7408041A/xx
Priority to BE145533A priority patent/BE816457A/xx
Priority to LU70329A priority patent/LU70329A1/xx
Priority to DE2429040A priority patent/DE2429040C2/de
Priority to AT504374A priority patent/AT343295B/de
Priority to JP49068809A priority patent/JPS5827280B2/ja
Priority to AU70148/74A priority patent/AU486806B2/en
Priority to GB364577A priority patent/GB1478357A/en
Priority to BR4979/74A priority patent/BR7404979D0/pt
Priority to GB2713174A priority patent/GB1478356A/en
Priority to IE1278/74A priority patent/IE41524B1/en
Publication of FR2235949A1 publication Critical patent/FR2235949A1/fr
Priority to ES448013A priority patent/ES448013A1/es
Priority to ES448012A priority patent/ES448012A1/es
Priority to AT986376A priority patent/AT351690B/de
Application granted granted Critical
Publication of FR2235949B1 publication Critical patent/FR2235949B1/fr
Priority to JP57189370A priority patent/JPS5934200B2/ja
Priority to JP57189371A priority patent/JPS5838440B2/ja
Priority to JP59073124A priority patent/JPS601200A/ja
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/823Immunogenic carrier or carrier per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7322114A 1973-06-18 1973-06-18 Expired FR2235949B1 (US06330241-20011211-M00004.png)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR7322114A FR2235949B1 (US06330241-20011211-M00004.png) 1973-06-18 1973-06-18
SE7407108A SE402461B (sv) 1973-06-18 1974-05-29 Steroidhaptener till anvendning for framstellning av antigener
DK322274A DK322274A (US06330241-20011211-M00004.png) 1973-06-18 1974-06-17
US479889A US3922292A (en) 1973-06-18 1974-06-17 Novel haptene steroids
CA202,616A CA1032927A (en) 1973-06-18 1974-06-17 Process for the preparation of new estrone-derived haptens
ZA00743841A ZA743841B (en) 1973-06-18 1974-06-17 New haptene steroids process for preparing them and their use in preparing antigens
NL7408041A NL7408041A (US06330241-20011211-M00004.png) 1973-06-18 1974-06-17
BE145533A BE816457A (fr) 1973-06-18 1974-06-17 Nouveaux haptenes steroides
LU70329A LU70329A1 (US06330241-20011211-M00004.png) 1973-06-18 1974-06-17
ES427318A ES427318A1 (es) 1973-06-18 1974-06-17 Procedimiento de preparacion de haptenos esteroides.
AT504374A AT343295B (de) 1973-06-18 1974-06-18 Verfahren zur herstellung neuer haptensteroide
JP49068809A JPS5827280B2 (ja) 1973-06-18 1974-06-18 シンキナハプテンステロイドノセイゾウホウオヨビ ソレノコウゲンノ セイゾウヘノシヨウ
DE2429040A DE2429040C2 (de) 1973-06-18 1974-06-18 Steroid-Haptene, Verfahren zu deren Herstellung und deren Verwendung
AU70148/74A AU486806B2 (en) 1974-06-18 Haptene steroids
GB364577A GB1478357A (en) 1973-06-18 1974-06-18 Haptene derivatives of estrogens processes for preparing them and methods of preparing antigens from them
BR4979/74A BR7404979D0 (pt) 1973-06-18 1974-06-18 Processo de preparacao de novos haptenos esteroides e aplicacao dos mesmos
GB2713174A GB1478356A (en) 1973-06-18 1974-06-18 Haptene derivatives of estrogens processes for preparing them and methods of preparing antigens from them
IE1278/74A IE41524B1 (en) 1973-06-18 1974-06-18 Novel haptene derivatives of estrogens process for prepariing them and methods of preparing antigens from them
ES448013A ES448013A1 (es) 1973-06-18 1976-05-17 Procedimiento de preparacion de haptenos esteroides.
ES448012A ES448012A1 (es) 1973-06-18 1976-05-17 Procedimiento de preparacion de haptenos esteroides.
AT986376A AT351690B (de) 1973-06-18 1976-12-30 Verfahren zur herstellung neuer haptensteroide
JP57189370A JPS5934200B2 (ja) 1973-06-18 1982-10-29 新規なハプテンステロイドの製造法
JP57189371A JPS5838440B2 (ja) 1973-06-18 1982-10-29 新規なハプテンステロイドの製造法
JP59073124A JPS601200A (ja) 1973-06-18 1984-04-13 新規なハプテンステロイドの製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7322114A FR2235949B1 (US06330241-20011211-M00004.png) 1973-06-18 1973-06-18

Publications (2)

Publication Number Publication Date
FR2235949A1 FR2235949A1 (US06330241-20011211-M00004.png) 1975-01-31
FR2235949B1 true FR2235949B1 (US06330241-20011211-M00004.png) 1978-03-17

Family

ID=9121104

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7322114A Expired FR2235949B1 (US06330241-20011211-M00004.png) 1973-06-18 1973-06-18

Country Status (16)

Country Link
US (1) US3922292A (US06330241-20011211-M00004.png)
JP (4) JPS5827280B2 (US06330241-20011211-M00004.png)
AT (1) AT343295B (US06330241-20011211-M00004.png)
BE (1) BE816457A (US06330241-20011211-M00004.png)
BR (1) BR7404979D0 (US06330241-20011211-M00004.png)
CA (1) CA1032927A (US06330241-20011211-M00004.png)
DE (1) DE2429040C2 (US06330241-20011211-M00004.png)
DK (1) DK322274A (US06330241-20011211-M00004.png)
ES (3) ES427318A1 (US06330241-20011211-M00004.png)
FR (1) FR2235949B1 (US06330241-20011211-M00004.png)
GB (2) GB1478357A (US06330241-20011211-M00004.png)
IE (1) IE41524B1 (US06330241-20011211-M00004.png)
LU (1) LU70329A1 (US06330241-20011211-M00004.png)
NL (1) NL7408041A (US06330241-20011211-M00004.png)
SE (1) SE402461B (US06330241-20011211-M00004.png)
ZA (1) ZA743841B (US06330241-20011211-M00004.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2277821A1 (fr) * 1974-07-10 1976-02-06 Roussel Uclaf Nouveaux haptenes derives de la progesterone, leur procede de preparation et leur application a la fabrication d'antigenes
FR2377417A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides substitues en 11b, ainsi que leur procede de preparation
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
CA1285866C (en) 1984-10-19 1991-07-09 Akiko Kubodera Immunoassay for estriol-3-sulfate
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
DE69128820T2 (de) * 1990-08-14 1998-06-10 Hoechst Marion Roussel Inc Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon
JPH059418U (ja) * 1991-07-12 1993-02-09 広島アルミニウム工業株式会社 電磁コンロ用発熱器
JPH07297707A (ja) * 1994-04-27 1995-11-10 Nec Corp 位相同期発振回路
DE69737791D1 (de) 1996-04-09 2007-07-19 Univ Edinburgh Verwendung von 7-alpha-substituierten steroiden zur behandlung von neuropsychiatrischen erkrankungen
DE602005023877D1 (de) * 2004-07-27 2010-11-11 Sicor Inc Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211756A (en) * 1963-07-23 1965-10-12 Searle & Co 3-hydroxyimino-17alpha-(lower alkyl)-5alpha-androstan-17beta-ols and the optionally substituted 3-acyloxyimino and 3-alkoxyimino derivatives corresponding
DE1668682A1 (de) * 1967-03-14 1971-09-23 Searle & Co Gegebenenfalls in 17-Stellung alkylierte 11,13ss-Dialkylgona-1,3,5(10)-trien-3,17ss-diole und deren Ester

Also Published As

Publication number Publication date
DE2429040C2 (de) 1985-10-31
BE816457A (fr) 1974-12-17
SE402461B (sv) 1978-07-03
IE41524B1 (en) 1980-01-30
IE41524L (en) 1974-12-18
DK322274A (US06330241-20011211-M00004.png) 1975-02-10
BR7404979D0 (pt) 1975-01-21
US3922292A (en) 1975-11-25
LU70329A1 (US06330241-20011211-M00004.png) 1975-03-06
JPS5036451A (US06330241-20011211-M00004.png) 1975-04-05
GB1478356A (en) 1977-06-29
ES427318A1 (es) 1976-09-16
JPS6241719B2 (US06330241-20011211-M00004.png) 1987-09-04
NL7408041A (US06330241-20011211-M00004.png) 1974-12-20
DE2429040A1 (de) 1975-01-09
ATA504374A (de) 1977-09-15
JPS5934200B2 (ja) 1984-08-21
AT343295B (de) 1978-05-26
SE7407108L (US06330241-20011211-M00004.png) 1974-12-19
JPS5838440B2 (ja) 1983-08-23
FR2235949A1 (US06330241-20011211-M00004.png) 1975-01-31
JPS5890597A (ja) 1983-05-30
GB1478357A (en) 1977-06-29
AU7014874A (en) 1975-12-18
ZA743841B (en) 1976-01-28
ES448012A1 (es) 1977-07-01
ES448013A1 (es) 1977-07-01
CA1032927A (en) 1978-06-13
JPS5890600A (ja) 1983-05-30
JPS601200A (ja) 1985-01-07
JPS5827280B2 (ja) 1983-06-08

Similar Documents

Publication Publication Date Title
AR201758A1 (US06330241-20011211-M00004.png)
AU476761B2 (US06330241-20011211-M00004.png)
AU465372B2 (US06330241-20011211-M00004.png)
AR201235Q (US06330241-20011211-M00004.png)
AR201231Q (US06330241-20011211-M00004.png)
AU471343B2 (US06330241-20011211-M00004.png)
AU465434B2 (US06330241-20011211-M00004.png)
FR2235949B1 (US06330241-20011211-M00004.png)
AU450229B2 (US06330241-20011211-M00004.png)
AR201229Q (US06330241-20011211-M00004.png)
AU447540B2 (US06330241-20011211-M00004.png)
AR195948A1 (US06330241-20011211-M00004.png)
AR201432A1 (US06330241-20011211-M00004.png)
AR193950A1 (US06330241-20011211-M00004.png)
AU461342B2 (US06330241-20011211-M00004.png)
AR210729A1 (US06330241-20011211-M00004.png)
AR195311A1 (US06330241-20011211-M00004.png)
AU1891376A (US06330241-20011211-M00004.png)
CH560477A5 (US06330241-20011211-M00004.png)
AU479562A (US06330241-20011211-M00004.png)
CH561917A5 (US06330241-20011211-M00004.png)
CH1173074A4 (US06330241-20011211-M00004.png)
CH563596A5 (US06330241-20011211-M00004.png)
CH564257A5 (US06330241-20011211-M00004.png)
CH565088A5 (US06330241-20011211-M00004.png)

Legal Events

Date Code Title Description
ST Notification of lapse